Separation and Release of Claims Agreement (May 10th, 2017)
This Separation and Release of Claims Agreement (the "Agreement") is made as of the Effective Date (as defined below) between Merrimack Pharmaceuticals, Inc. (the "Company") and Edward J. Stewart ("Executive") (together, the "Parties").
Confidential Execution Version (November 10th, 2014)
This License and Collaboration Agreement (this Agreement), dated the 23rd day of September, 2014 (the Effective Date), is by and among BAXTER INTERNATIONAL INC., a company organized under the laws of Delaware with its principal place of business at One Baxter Parkway, Deerfield, IL 60015, US (BII), BAXTER HEALTHCARE CORPORATION, a company organized under the laws of Delaware with its principal place of business at One Baxter Parkway, Deerfield, IL 60015, US (BHC), and BAXTER HEALTHCARE SA, a company organized under the laws of Switzerland with its principal place of business at Postfach 8010, Zurich, Switzerland (BHSA and together with BII and BHC, BAXTER), on the one hand, and MERRIMACK PHARMACEUTICALS, INC., a Delaware corporation with its principal offices at One Kendall Square, Suite B7201, Cambridge, MA 02139, US (MERRIMACK), on the other hand.
Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. FIRST AMENDMENT TO ASSIGNMENT, SUBLICENSE AND COLLABORATION AGREEMENT (November 10th, 2014)
This First Amendment to Assignment, Sublicense and Collaboration Agreement (this Amendment), dated as of September 22, 2014 (the Amendment Effective Date), is by and between Merrimack Pharmaceuticals (Bermuda) Ltd. (MERRIMACK) and PharmaEngine, Inc. (PEI).
Amendment to Amended and Restated Collaboration Agreement (March 20th, 2013)
This AMENDMENT (the Amendment), dated as of January 18, 2012 (the Amendment Date), further amends the AMENDED AND RESTATED COLLABORATION AGREEMENT, dated January 24, 2007, as previously amended on July 31, 2008 and November 6, 2009 (the Amended Agreement) between DYAX CORP. (Dyax) and MERRIMACK PHARMACEUTICALS, INC. (Merrimack). Terms not otherwise defined herein shall have the respective meanings attributed to them in the Amended Agreement.